Skip to main content
Clinical Trials/NCT03125005
NCT03125005CompletedNot Applicable

Accuracy of Methemoglobin Measurement for Rainbow Universal Pulse Oximeter Sensor

Masimo Corporation2 sites in 1 country51 target enrollmentStarted: April 12, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
51
Locations
2
Primary Endpoint
Accuracy of Sensor by Arms Calculation

Study Overview

Brief Summary

In this study, the level of methemoglobin (HbMet) will be increased in a controlled manner by administering sodium nitrite intravenously in healthy volunteers. The accuracy of a noninvasive HbMet sensor will be assessed by comparison to blood measurements from a laboratory analyzer.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •The subject is male or female, aged ≥18 and <
  • •The subject is in good general health with no evidence of any medical problems.
  • •The subject is fluent in both written and spoken English.
  • •The subject has provided informed consent and is willing to comply with the study procedures.

Exclusion Criteria

  • •The subject is obese (BMI>30).
  • •The subject has a known history of heart disease, lung disease, kidney or liver disease.
  • •Diagnosis of asthma, sleep apnea, or use of CPAP.
  • •Subject has diabetes.
  • •Subject has a clotting disorder.
  • •The subject has a hemoglobinopathy or history of anemia, per subject report or the first blood sample, that in the opinion of the investigator, would make them unsuitable for study participation.
  • •The subject has any other serious systemic illness.
  • •The subject is a current smoker.
  • •Any injury, deformity, or abnormality at the sensor sites that in the opinion of the investigators' would interfere with the sensors working correctly.
  • •The subject has a history of fainting or vasovagal response.
  • •The subject has a history of sensitivity to local anesthesia or allergy to the study drugs.
  • •The subject has a diagnosis of Raynaud's disease.
  • •The subject has unacceptable collateral circulation based on exam by the investigator (Allen's test).
  • •The subject is pregnant, lactating or trying to get pregnant.
  • •The subject has a history of migraine headaches.
  • •The subject is currently taking antidepressants.
  • •The subject is unable or unwilling to provide informed consent, or is unable or unwilling to comply with study procedures.
  • •The subject has any other condition, which in the opinion of the investigators' would make them unsuitable for the study.

Arms & Interventions

Rainbow Universal Pulse Oximeter Sensor

Experimental

All subjects will be enrolled in the test group and will receive Rainbow Universal Pulse Oximeter Sensor.

Intervention: Rainbow Universal Pulse Oximeter Sensor (Device)

Outcomes

Primary Outcomes

Accuracy of Sensor by Arms Calculation

Time Frame: 5 hours

Accuracy willl be determined by comparing the noninvasive blood methemoglobin measurement (expressed as a percentage of total hemoglobin) of the pulse oximeter to that obtained from a blood sample and calculating the arithmetic root mean square(Arms) error value.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials